For those interested in participating in the precisionFDA Gaining New Insights by Detecting Adverse Event Anomalies Using FDA Open Data Challenge, you have 10-days days to complete your submission. Selected participants will be invited to participate in a panel at the Modernizing FDA’s Data Strategy public meeting. Final submissions are due on February 28th, and providing code is no longer required for a valid entry. Additionally, new guidance is available on the challenge site including updated evaluation criteria and anomaly examples.
If you are interested in learning more about how FDA is modernizing its data strategy, please attend the Modernizing FDA’s Data Strategy public meeting on March 27th. The meeting will also be streamed virtually for those who don’t live in the DC area.
If you have any questions about the challenge, please feel free to post them in this thread and we will respond as quickly as possible.

Reply

  • deer_donald Doug Deer 21 Feb 2020

    We are pleased to announce that the Journal of the American Medical Informatics Association (JAMIA) supports the submission of a paper describing the precisionFDA Gaining New Insights by Detecting Adverse Event Anomalies Using FDA Open Data challenge and broadly applicable insights that emerge from it. Publication in JAMIA will be contingent on a standard evaluation process including editorial assessment and peer review.
    As a friendly reminder for those of you participating in the challenge you have one week left before final submissions are due on February 28th at https://go.usa.gov/xdEWr.
    If you have any questions about the challenge, please feel free to post them in this thread and we will respond as quickly as possible.

  • deer_donald Doug Deer 25 Feb 2020

    In response to a flurry of new interest in the Gaining New Insights by Detecting Adverse Event Anomalies Using FDA Open Data Challenge we have decided to extend the submission period to March 13th. New guidance is available on the challenge site including updated evaluation criteria and anomaly examples.

    Please also note that providing code is no longer required for a valid final submission. Selected contributors will be invited to participate in a panel at the Modernizing FDA’s Data Strategy public meeting. We are also pleased to announce that the Journal of the American Medical Informatics Association (JAMIA) supports the submission of a paper describing the challenge and the insights that emerge from it.

    If you are interested in learning more about how FDA is modernizing its data strategy, please attend the Modernizing FDA’s Data Strategy public meeting on March 27th. The meeting will also be streamed virtually for those who don’t live in the DC area!

    If you have any questions about the challenge, please feel free to post them in this thread and we will respond as quickly as possible.

Please Sign in (or Register) to view further.